PLX vs. ORE.TO
PLX (Protalix BioTherapeutics, Inc.) and ORE.TO (Orezone Gold Corporation) are both stocks. PLX operates in Biotechnology (Healthcare), while ORE.TO operates in Gold (Basic Materials). Over the past 10 years, PLX returned -13.01%/yr vs 9.17%/yr for ORE.TO. At a 0.07 correlation, their price movements are largely independent.
Performance
PLX vs. ORE.TO - Performance Comparison
Loading charts...
Different Trading Currencies
PLX is traded in USD, while ORE.TO is traded in CAD. To make them comparable, the ORE.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, PLX achieves a 8.89% return, which is significantly lower than ORE.TO's 45.64% return. Over the past 10 years, PLX has underperformed ORE.TO with an annualized return of -13.01%, while ORE.TO has yielded a comparatively higher 9.17% annualized return.
PLX
- 1D
- -1.51%
- 1M
- -7.98%
- YTD
- 8.89%
- 6M
- 13.95%
- 1Y
- 22.50%
- 3Y*
- -3.92%
- 5Y*
- -1.74%
- 10Y*
- -13.01%
ORE.TO
- 1D
- -1.16%
- 1M
- 31.18%
- YTD
- 45.64%
- 6M
- 57.84%
- 1Y
- 78.93%
- 3Y*
- 25.37%
- 5Y*
- 11.78%
- 10Y*
- 9.17%
PLX vs. ORE.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PLX Protalix BioTherapeutics, Inc. | 8.89% | -4.26% | 5.62% | 29.93% | 64.72% | -77.09% | 10.67% | 5.47% | -52.96% | 48.58% |
ORE.TO Orezone Gold Corporation | 45.64% | 189.82% | -30.65% | -31.00% | -2.03% | 9.90% | 70.00% | 21.57% | -25.95% | 43.21% |
Correlation
The correlation between PLX and ORE.TO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since May 6, 2009 | 0.07 |
Fundamentals
PLX:
$162.78M
ORE.TO:
CA$1.75B
PLX:
$0.19
ORE.TO:
CA$0.14
PLX:
10.34
ORE.TO:
18.72
PLX:
2.08
ORE.TO:
3.45
PLX:
1.72
ORE.TO:
3.22
PLX:
$76.38M
ORE.TO:
CA$478.80M
PLX:
$53.44M
ORE.TO:
CA$224.13M
PLX:
$20.91M
ORE.TO:
CA$235.40M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PLX vs. ORE.TO — Risk / Return Rank
PLX
ORE.TO
PLX vs. ORE.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Protalix BioTherapeutics, Inc. (PLX) and Orezone Gold Corporation (ORE.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PLX | ORE.TO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.34 | 1.25 | -0.91 |
Sortino ratioReturn per unit of downside risk | 0.92 | 1.83 | -0.90 |
Omega ratioGain probability vs. loss probability | 1.12 | 1.23 | -0.11 |
Calmar ratioReturn relative to maximum drawdown | 0.57 | 2.37 | -1.80 |
Martin ratioReturn relative to average drawdown | 1.07 | 4.75 | -3.68 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PLX | ORE.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.34 | 1.25 | -0.91 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.03 | 0.20 | -0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.16 | 0.14 | -0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.07 | 0.16 | -0.22 |
Drawdowns
PLX vs. ORE.TO - Drawdown Comparison
The maximum PLX drawdown since its inception was -99.91%, roughly equal to the maximum ORE.TO drawdown of -96.92%. Use the drawdown chart below to compare losses from any high point for PLX and ORE.TO.
Loading charts...
Drawdown Indicators
| PLX | ORE.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.91% | -96.92% | -2.99% |
Max Drawdown (1Y)Largest decline over 1 year | -39.68% | -33.45% | -6.23% |
Max Drawdown (3Y)Largest decline over 3 years | -62.96% | -58.97% | -3.99% |
Max Drawdown (5Y)Largest decline over 5 years | -73.21% | -71.66% | -1.55% |
Max Drawdown (10Y)Largest decline over 10 years | -94.37% | -83.35% | -11.02% |
Current DrawdownCurrent decline from peak | -99.78% | -64.32% | -35.46% |
Average DrawdownAverage peak-to-trough decline | -93.66% | -74.85% | -18.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.01% | 16.75% | +4.26% |
Volatility
PLX vs. ORE.TO - Volatility Comparison
The current volatility for Protalix BioTherapeutics, Inc. (PLX) is 13.87%, while Orezone Gold Corporation (ORE.TO) has a volatility of 15.20%. This indicates that PLX experiences smaller price fluctuations and is considered to be less risky than ORE.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PLX | ORE.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.87% | 15.20% | -1.33% |
Volatility (6M)Calculated over the trailing 6-month period | 44.36% | 47.72% | -3.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.69% | 63.59% | +3.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.72% | 60.20% | +7.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.33% | 65.57% | +13.76% |
Dividends
PLX vs. ORE.TO - Dividend Comparison
Neither PLX nor ORE.TO has paid dividends to shareholders.
Financials
PLX vs. ORE.TO - Financials Comparison
This section allows you to compare key financial metrics between Protalix BioTherapeutics, Inc. and Orezone Gold Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PLX vs. ORE.TO - Profitability Comparison
PLX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Protalix BioTherapeutics, Inc. reported a gross profit of 29.62M and revenue of 33.75M. Therefore, the gross margin over that period was 87.8%.
ORE.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Orezone Gold Corporation reported a gross profit of 93.46M and revenue of 182.89M. Therefore, the gross margin over that period was 51.1%.
PLX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Protalix BioTherapeutics, Inc. reported an operating income of 21.15M and revenue of 33.75M, resulting in an operating margin of 62.7%.
ORE.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Orezone Gold Corporation reported an operating income of 85.37M and revenue of 182.89M, resulting in an operating margin of 46.7%.
PLX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Protalix BioTherapeutics, Inc. reported a net income of 18.32M and revenue of 33.75M, resulting in a net margin of 54.3%.
ORE.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Orezone Gold Corporation reported a net income of 38.91M and revenue of 182.89M, resulting in a net margin of 21.3%.
Frequently Asked Questions
PLX and ORE.TO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for PLX and ORE.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer